Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

By Oliver Hirt ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

Among the arrested was a 15-year-old student, for suspected drug abuse. Read more at straitstimes.com. Read more at ...

The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose “a major tariff” ...

A coast guard official said the smugglers spotted the patrol ship from their fishing boat half a mile inside Indian waters ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Research on the biological basis of addiction has found that the critical epigenetic enzyme histone deacetylase 5 (HDAC5) limits the expression of the gene Scn4b, regulating neuronal activity and ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Pfizer said on Monday it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...